GlassScriptPhysician profile
Marc Anthony Barbella
NPI 1154416352
$5,328.57
in general payments reported to CMS, 2019-2025
29 companies · $544 in 2025
The $544 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,206 · 2020: $415 · 2021: $919 · 2022: $1,124 · 2023: $922 · 2024: $198 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,664.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,904.35 | 2019-2025 | Citrefix, Easyfuse, Anchorage |
| Smith+Nephew, INC. | $850.08 | 2019-2025 | Grafix Pl, Stravix, Stravix Pl |
| Organogenesis INC. | $340.17 | 2019-2023 | Puraply |
| Kci USA, INC. | $256.43 | 2021-2023 | Activ.A.C., Promogran Prisma, V.A.C. Veraflo |
| Kerecis Limited | $234.60 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bioventus LLC | $225.62 | 2020-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Linvatec Corporation | $191.49 | 2023-2025 | Allograft Tissue, Colink Plating System, Neospan |
| Paratek Pharmaceuticals, INC. | $137.34 | 2022 | |
| Urgo Medical North America, LLC | $127.56 | 2025 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Integra Lifesciences Corporation | $111.55 | 2022 | |
| Anika Therapeutics, INC. | $99.71 | 2023 | X-Twist, Toe Motion, Tactoset |
| Tenex Health INC. | $97.51 | 2021 | |
| Depuy Synthes Sales INC. | $96.53 | 2023 | Hammerlock |
| Checkpoint Surgical, INC | $86.63 | 2022 | |
| Biotissue Holdings INC. | $84.63 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $72.38 | 2023-2024 | Proclaim |
| Trice Medical, INC. | $58.19 | 2024 | |
| Misonix INC | $53.10 | 2019-2020 | |
| Convatec INC. | $47.33 | 2019-2023 | |
| Tactile Systems Technology INC | $41.67 | 2019 | |
| Melinta Therapeutics, LLC | $36.41 | 2019 | |
| Grt US Holding, INC. | $34.80 | 2022 | |
| Boston Scientific Corporation | $31.22 | 2022-2024 | |
| Vertex Pharmaceuticals Incorporated | $26.87 | 2025 | |
| Abbvie INC. | $25.49 | 2022 | |
| Heron Therapeutics, INC. | $19.96 | 2022 | |
| Innovation Technologies INC | $17.24 | 2025 | Irrisept |
| Reprise Biomedical, INC. | $13.84 | 2025 | Miro3d |
| Lifenet Health | $5.87 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Barbella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.